MedTrace Logo

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

NCT04634630 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2021-06-01

No results posted yet for this study

Summary

The present study is a prospective cohort study. The aim is to assess the relationship between the presence of cancer stem-cells (CSC) and the risk of relapse in patients with early and locally advanced adenocarcinoma and squamous cell carcinoma of the lung

Conditions

  • Lung Cancer, Nonsmall Cell
  • Relapse/Recurrence
  • CSC

Interventions

GENETIC

Exposure to lung cancer stem cells

The exposure to lung cancer stem cells was measure as the percentage of Aldehyde dehydrogenase (ALDH) on all viable cells extracted from surgically resected tumor specimens

Sponsors & Collaborators

  • Beatrice Aramini

    lead OTHER

Principal Investigators

  • Uliano Morandi, MD · Azienda Ospedaliero-Universitaria di Modena

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-17
Primary Completion
2020-10-17
Completion
2020-10-17

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04634630 on ClinicalTrials.gov